Powered by: Motilal Oswal
Menu
Close X
Nippon India Pharma Fund(IDCW)

Scheme Returns

11.32%

Category Returns

8.73%

Riskometer

  • Low
  • Low to moderate
  • Moderate
  • Moderately High
  • High
  • Very High

NAV Chart

Trailing Returns

1 Day 1 week 1 Mth 3 Mth 1 Yrs 3 Yrs 4 Yrs 5 Yrs Since Inception
Nippon India Pharma Fund(IDCW) 0.85 1.02 11.32 3.52 14.27 16.91 19.94 14.37 19.78
Equity - Sectoral Fund - Pharma & Health Care 0.68 1.08 8.73 0.72 4.78 14.06 17.03 14.68 16.37

* Equity - Returns upto 1 year are absolute and over 1 year are CAGR.

* Debt - Returns upto 1 year are annualized and over 1 year are CAGR.

  • AMC

    Nippon Life India Asset Management Limited

  • Fund

    Nippon India Mutual Fund

Snapshot

  • Inception Date

    05-Jun-2004

  • Initial Price

    ₹10

  • Entry Load

    --

  • Size of Fund(in Cr.)

    20,084.63

  • Scheme Plan

    --

  • Scheme Class

    Equity - Sectoral Fund - Pharma & Health Care

  • Objectives

    The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

  • Scheme Type

    Open ended scheme

  • Min. Investment

    ₹5,000

  • Exit Load

    1

  • Latest NAV

    127.6754

  • Fund Manager

    Mr. Sailesh Raj Bhan

  • Fund Manager Profile

    Sailesh has Over 10 years experience in Equity Securities research and analysis. he is in Reliance Capital Asset Management Limited as managing various Schemes of Reliance Mutual Fund From 2003 to till date

  • Fund Information

  • AMC

    Nippon Life India Asset Management Limited

  • Address

    4th Floor, Tower A, Peninsula Business Park, Ganapatrao Kadam Marg, Lower Parel (W) Mumbai - 400 013

  • Phone

    022-68087000

  • Fax

    022-68087097

  • Email

    customercare@nipponindiaim.in

  • Website

    https://mf.nipponindiaim.com/

  • Registrar Agent

  • Registrar

    KFin Technologies Limited

  • Address

    301, Centrium, 3rd Floor, 57, L.B.S. Road Nav Pada, Kurla (West) Mumbai - 400070

  • Phone

    022 - 4617 0911

  • Fax

  • Email

    investorsupport.mfs@kfintech.com

  • Website

    https://mfs.kfintech.com/

Portfolio Details

Allocation
Equity : 99.6
Others : 0.4

Companies - Holding Percentage

Company Market Value hold percentage
Sun Pharmaceutical Industries Limited 104997.17 11.55
Divi's Laboratories Limited 61198.74 6.73
Cipla Limited 56466.7 6.21
Lupin Limited 55986.06 6.16
Dr. Reddy's Laboratories Limited 55682.2 6.13
Apollo Hospitals Enterprise Limited 46362.2 5.1
Mankind Pharma Limited 39973.59 4.4
Sai Life Sciences Limited 36690.73 4.04
Ajanta Pharma Limited 32067.55 3.53
Max Healthcare Institute Limited 30083.51 3.31
IPCA Laboratories Limited 26309.5 2.9
GlaxoSmithKline Pharmaceuticals Limited 25677.82 2.83
Gland Pharma Limited 24784.2 2.73
Vijaya Diagnostic Centre Limited 24166.58 2.66
Piramal Pharma Limited 23741.14 2.61
MedPlus Health Services Limited 20558.78 2.26
Fortis Healthcare Limited 20404.36 2.25
Abbott India Limited 20135.27 2.22
Dr. Lal Path Labs Limited 19075.02 2.1
Thyrocare Technologies Limited 17512.64 1.93
Alkem Laboratories Limited 16551.27 1.82
Narayana Hrudayalaya Limited 14172.92 1.56
Syngene International Limited 14100.53 1.55
Aurobindo Pharma Limited 12892.54 1.42
Suraksha Diagnostic Limited 12326.1 1.36
Emcure Pharmaceuticals Limited 11996.55 1.32
Anthem Biosciences Limited 11769.29 1.3
Pfizer Limited 11736.39 1.29
Akums Drugs and Pharmaceuticals Limited 9890.18 1.09
Sanofi India Limited 9621.02 1.06
Biocon Limited 8809.32 0.97
Natco Pharma Limited 8136.96 0.9
Sanofi Consumer Healthcare India Limited 7354.78 0.81
Molbio Diagnostics Limited 4844.93 0.53
Triparty Repo 4734.89 0.52
AstraZeneca Pharma India Limited 4215.21 0.46
Indoco Remedies Limited 3440.34 0.38
Concord Biotech Limited 1391.81 0.15
Cash Margin - CCIL 17.99 0
Net Current Assets -1152.07 -0.13

Sectors - Holding Percentage

Sector hold percentage
Healthcare 95.79%
Retailing 2.26%
Business Services 1.55%
Miscellaneous 0.52%

Divident Details

Scheme Name Date Dividend (%)
Nippon India Pharma Fund 05-03-2018 6
Nippon India Pharma Fund 05-03-2019 5
Nippon India Pharma Fund 02-03-2020 4.5
Nippon India Pharma Fund 01-03-2021 6
Nippon India Pharma Fund 28-02-2022 3.5
Nippon India Pharma Fund 26-02-2024 10
Nippon India Pharma Fund 21-02-2025 10
Nippon India Pharma Fund 06-02-2026 8.5

Alternative Funds From Category

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) 1637.91 12.88 5.12 16.49 26 23.51
UTI Healthcare Fund - Regular Plan - IDCW 682.85 11.29 3.49 13.42 21.6 22.05
NIPPON INDIA PHARMA FUND - IDCW Option 200.85 11.32 3.52 8.09 14.27 16.91

Other Funds From - Nippon India Pharma Fund(IDCW)

Scheme Name Asset Size 1M 3M 6M 1Y 3Y
Nippon India Small Cap Fund - Growth Plan - Growth Option 82580.31 1.66 -3.45 4.7 5.62 11.93
Nippon India Small Cap Fund - Growth Plan - Growth Option 80905.55 1.66 -3.45 4.7 5.62 11.93
Nippon India Small Cap Fund - Growth Plan - Growth Option 78407.03 1.66 -3.45 4.7 5.62 11.93
Nippon India Small Cap Fund - Growth Plan - Growth Option 77864.92 1.66 -3.45 4.7 5.62 11.93
Nippon India Small Cap Fund - Growth Plan - Growth Option 76902.83 1.66 -3.45 4.7 5.62 11.93
Nippon India Small Cap Fund - Growth Plan - Growth Option 74484.5 1.66 -3.45 4.7 5.62 11.93
Nippon India Small Cap Fund - Growth Plan - Growth Option 72672.99 1.66 -3.45 4.7 5.62 11.93
Nippon India Small Cap Fund - Growth Plan - Growth Option 68969.15 1.66 -3.45 4.7 5.62 11.93
Nippon India Small Cap Fund - Growth Plan - Growth Option 68571.85 1.66 -3.45 4.7 5.62 11.93
Nippon India Small Cap Fund - Growth Plan - Growth Option 68287.15 1.66 -3.45 4.7 5.62 11.93